Matthews International: Q1 Earnings Insights

Matthews International (NASDAQ:MATW) reported its Q1 earnings results on Thursday, February 1, 2024 at 04:15 PM. Here’s what…

Matthews International (NASDAQ:MATW) reported its Q1 earnings results on Thursday, February 1, 2024 at 04:15 PM.

Here’s what investors need to know about the announcement.

Earnings

Matthews International reported in-line EPS of $0.37 versus an estimate of $0.37.

Revenue was up $746 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.06 which was followed by a 3.85% drop in the share price the next day.

Here’s a look at Matthews International’s past performance:

Quarter Q4 2023 Q3 2023 Q2 2023 Q1 2023
EPS Estimate 0.90 0.63 0.51 0.54
EPS Actual 0.96 0.74 0.65 0.53
Revenue Estimate 483.00M 464.28M 448.14M 431.60M
Revenue Actual 480.17M 471.91M 479.58M 449.24M

To track all earnings releases for Matthews International visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Cannara Biotech Reports 51% YoY Revenue Increase In Q2, Wider Net Loss

Cannara Biotech Inc. announced on Monday its fiscal second quarter 2024 financial and operating results for the three and six-month periods ended Feb. 29, 2024. The company reported a 68% year-over-year increase in revenues for the first half of fiscal 2024, a metrics CFO Nicholas Sosiak called "a testament to our growing influence in the Quebec, Ontario, Alberta, and BC markets." "Our proactive steps towards streamlining assets align with our ambition to fortify our financial foundation as we relentlessly stay focused on gaining market share and becoming the leader in Canada, the second-largest cannabis market in the world," Sosiak said. "As for our long-term vision, we do see our future extend beyond our borders where Cannara is a globally recognized brand synonymous with excellence and value in cannabis."

LOVE